An Opinion Piece on Transparency, Pharmaceutical Interests, and the Curious Timing of Hemp Industry Regulations

---

Donald Trump has always prided himself on being a dealmaker. His book, The Art of the Deal, famously acknowledges that not everyone walks away happy when the ink dries. That’s the nature of negotiation—someone wins, someone loses, and often, the details remain hidden from those most affected by the outcome.I’ve been paying close attention to the deals coming out of this administration, and I find it troubling that the American public rarely learns what’s actually in them. We hear the headlines. We see the press conferences. But the fine print? That stays behind closed doors.

---

The Lower Drug Prices Announcement

Let’s take the recent announcement on lower drug prices. On the surface, it sounds like a win for consumers. Who wouldn’t want more affordable medications?But here’s the question no one seems to be asking: What did the pharmaceutical industry get in return?Deals are, by definition, exchanges. If drug companies agreed to lower their prices, what incentive did they receive? What concession was made on their behalf?

---

A Curious Coincidence: The Federal Crackdown on Hemp

Shortly after the lower drug prices were announced, federal agencies turned their attention to the hemp industry with surprising intensity. For those who follow both markets, the timing raised eyebrows.Was this a coincidence? Perhaps. But consider this: hemp and CBD products have emerged as direct competitors to a wide range of pharmaceutical drugs—often at a fraction of the cost and without requiring a prescription or doctor’s visit.Could restricting the hemp industry have been part of the deal?

---

What Hemp and CBD Offer Consumers

To understand why pharmaceutical companies might view the hemp industry as a threat, consider the health benefits these products claim to provide:CBD (Cannabidiol) Benefits:

• Pain Relief – Interacts with the endocannabinoid system to reduce inflammation
• Anxiety and Stress Reduction – Helps alleviate symptoms of anxiety disorders
• Sleep Improvement – Promotes relaxation and reduces insomnia
• Epilepsy Treatment – FDA-approved (Epidiolex) for rare seizure disorders
• Neuroprotective Properties – Potential benefits for Parkinson’s, Alzheimer’s, and MS
• Anti-inflammatory Effects – May benefit arthritis and autoimmune conditions
• Addiction Management – May help reduce cravings and withdrawal symptoms
• Heart Health – Could lower blood pressure and improve cardiovascular function
• Skin Conditions – Topical applications for acne, eczema, and psoriasis

Hemp Seeds, Oil, and Protein Benefits:

• Nutrient-Rich – High in vitamins E, D, and A, plus essential minerals
• Complete Protein – Contains all 9 essential amino acids
• Heart Health – Omega-3 and omega-6 fatty acids improve cholesterol levels
• Digestive Health – High fiber supports gut health
• Hormonal Balance – GLA may reduce PMS and menopause symptoms
• Energy and Weight Management – Promotes sustained energy and satiety

Note: While these benefits are promising, more research is needed, and individual results may vary.

---

The Competition: Pharmaceutical Alternatives

Now consider the pharmaceutical drugs that treat these same conditions—and the prices attached to them:

Condition	Pharmaceutical Options
Pain Relief	Opioids (OxyContin, Vicodin), NSAIDs (Celebrex), Gabapentin, Lyrica
Anxiety/Stress	Zoloft, Lexapro, Xanax, Ativan, Valium
Sleep Issues	Ambien, Lunesta, Trazodone
Epilepsy	Depakote, Keppra, Lamictal, Epidiolex
Inflammation	Prednisone, Methotrexate, Humira
Addiction	Suboxone, Methadone, Chantix
Heart Health	Lipitor, Crestor, Lisinopril
Skin Conditions	Tretinoin, Protopic, Humira
Digestive Issues	Remicade, Asacol, Miralax
Hormonal Balance	HRT, oral contraceptives, SSRIs

These medications require prescriptions, doctor visits, and often expensive medical tests. They generate billions in revenue for pharmaceutical companies—and for the broader healthcare system.

---

Who Wins and Who Loses?

Here’s the central question: If you can walk into a local vape shop and try hemp products—much like visiting GNC for supplements—who benefits, and who loses?When consumers can self-select affordable, over-the-counter alternatives to treat common symptoms, the following parties see reduced revenue:

• Pharmaceutical companies – Fewer prescriptions filled
• Doctors and clinics – Fewer office visits
• Imaging centers and hospitals – Fewer diagnostic tests
• Pharmacies – Lower prescription volume

Conversely, if hemp products are restricted or banned, consumers are funneled back into the traditional healthcare pipeline—often seeing a PA or NP instead of a physician, cycling through multiple medications to find one that works, and paying significantly more in the process.

---

The Call for Transparency

Here’s my bottom line: There needs to be full transparency in these deals.After recent revelations about mismanaged funds in learning centers and other federally funded programs, it’s clear we need stronger oversight mechanisms. We have the IRS to track tax compliance—why don’t we have an equivalent agency to track where our tax dollars actually go and to provide public accountability for these high-stakes agreements?The American people deserve to know:

• What concessions were made in the drug pricing deal?
• Why did the federal crackdown on hemp follow so closely?
• Who benefits from these arrangements—and at whose expense?

Until we get answers, we’re left speculating about deals made in our name but without our knowledge.

---

What do you think? Is there a connection between lower drug prices and the hemp crackdown, or is it just coincidence? Share your thoughts in the comments below.

• LifeStyle